Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

This study is ongoing, but not recruiting participants.

Study NCT00098852 Information provided by National Cancer Institute (NCI)

First Received: December 8, 2004 Last Updated: September 25, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

Publications:

Kebebew E, Reiff E, Greenspan FS, et al.: Rosiglitazone treatment induces radioiodine uptake in some patients with radioiodine-negative thyroglobulin-positive differentiated thyroid cancer. [Abstract] The Endocrine Society's 87th Annual Meeting, 4-7 June 2005, San Diego, CA. A-P3-573, 2005. Also available online. Last accessed February 21, 2006.